Movement Behavior during Pregnancy and Adverse Maternal-Fetal Outcomes in Women with Gestational Diabetes: A Pilot Case-Control Study

被引:2
作者
Camargo, Savio F. [1 ,2 ]
Camargo, Juliana D. [2 ]
Schwade, Daniel [3 ]
Silva, Raissa M. [4 ]
Cornetta, Maria da Conceicao M. [2 ]
Cobucci, Ricardo N. [2 ,5 ]
Costa, Eduardo C. [1 ,4 ]
机构
[1] Univ Fed Rio Grande do Norte, Grad Program Hlth Sci, BR-59010000 Natal, RN, Brazil
[2] Univ Fed Rio Grande do Norte, Matern Hosp, Sch Januario Cicco, BR-59010000 Natal, RN, Brazil
[3] Univ Manitoba, Fac Kinesiol & Recreat Management, Hlth Leisure & Human Performance Res Inst, Winnipeg, MB R3B 2E9, Canada
[4] Univ Fed Rio Grande do Norte, Dept Phys Educ, BR-59010000 Natal, RN, Brazil
[5] Univ Potiguar, Grad Program Biotechnol, BR-59010000 Natal, RN, Brazil
关键词
gestational diabetes; health outcomes; physical activity; sedentary behavior; PHYSICAL-ACTIVITY PATTERNS; PRENATAL EXERCISE; MELLITUS; INTERVENTION; PREVENTION; STATEMENT; RISK;
D O I
10.3390/ijerph18031114
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Gestational diabetes mellitus (GDM) is a major complication in pregnancy. GDM is associated with a higher risk for adverse maternal-fetal outcomes. Associations between movement behavior, including physical activity (PA) and sedentary behavior (SB), and maternal-fetal outcomes are still unclear. The objective of this study was to investigate associations between movement behavior and adverse maternal-fetal outcomes in women with GDM. A total of 68 women with GDM (20-35 weeks, 32.1 +/- 5.8 years) were included in this pilot case-control study. The cases were defined by the presence of an adverse composite maternal-fetal outcome (preterm birth, newborn large for gestational age, and neonatal hypoglycemia). Controls were defined as no adverse maternal-fetal outcome. PA intensities and domains, steps/day (pedometer), and SB were analyzed. A total of 35.3% of participants showed adverse maternal-fetal outcomes (n = 24). The controls showed a higher moderate-intensity PA level than the cases (7.5, 95%CI 3.6-22.9 vs. 3.1, 95%CI 0.4-10.3 MET-h/week; p = 0.04). The moderate-intensity PA level was associated with a lower risk for adverse maternal-fetal outcomes (OR 0.21, 95%CI 0.05-0.91). No significant associations were observed for other PA and SB measures (p > 0.05). In conclusion, moderate-intensity PA during pregnancy seems to have a protective role against adverse maternal-fetal outcomes in women with GDM.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [41] The impact of fetal sex on risk factors for gestational diabetes and related adverse pregnancy outcomes
    Giuseppe Seghieri
    Graziano Di Cianni
    Elisa Gualdani
    Alessandra De Bellis
    Flavia Franconi
    Paolo Francesconi
    Acta Diabetologica, 2022, 59 : 633 - 639
  • [42] Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes
    Castillo, Wendy Camelo
    Boggess, Kim
    Stuermer, Til
    Brookhart, Alan
    Benjamin, Daniel K., Jr.
    Funk, Michele Jonsson
    JAMA PEDIATRICS, 2015, 169 (05) : 452 - 458
  • [43] Insulin sensitivity, β cell function, and adverse pregnancy outcomes in women with gestational diabetes
    Shen, Yun
    Zheng, Yanwei
    Su, Yingying
    Jiang, Susu
    Ma, Xiaojing
    Hu, Jiangshan
    Li, Changbin
    Huang, Yajuan
    Teng, Yincheng
    Bao, Yuqian
    Tao, Minfang
    Zhou, Jian
    CHINESE MEDICAL JOURNAL, 2022, 135 (21) : 2541 - 2546
  • [44] The effects of gestational diabetes on lower urinary tract symptoms of pregnant women: a case-control study
    Yavuz, Adem
    Kocaoz, Semra
    Kara, Pinar
    Destegul, Emre
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (08) : 3531 - 3536
  • [45] Are insulin sensitivity and β-cell function associated with adverse pregnancy outcomes among women with gestational diabetes?
    Hu, Gang
    CHINESE MEDICAL JOURNAL, 2022, 135 (21) : 2521 - 2524
  • [46] Меtformin-associated maternal and neonatal outcomes in women with gestational diabetes - a retrospective cohort study
    Yanachkova, Vesselina Evtimova
    Staynova, Radiana
    Stoev, Svetoslav
    Kamenov, Zdravko
    GINEKOLOGIA POLSKA, 2024, 95 (04) : 259 - 265
  • [47] Protocol for development and validation of a clinical prediction model for adverse pregnancy outcomes in women with gestational diabetes
    Cooray, Shamil D.
    Boyle, Jacqueline A.
    Soldatos, Georgia
    Zamora, Javier
    Fernandez Felix, Borja M.
    Allotey, John
    Thangaratinam, Shakila
    Teede, Helena J.
    BMJ OPEN, 2020, 10 (11):
  • [48] The risk stratification of adverse neonatal outcomes in women with gestational diabetes (STRONG) study
    Pintaudi, Basilio
    Fresa, Raffaella
    Dalfra, Mariagrazia
    Dodesini, Alessandro Roberto
    Vitacolonna, Ester
    Tumminia, Andrea
    Sciacca, Laura
    Lencioni, Cristina
    Marcone, Teresa
    Lucisano, Giuseppe
    Nicolucci, Antonio
    Bonomo, Matteo
    Napoli, Angela
    ACTA DIABETOLOGICA, 2018, 55 (12) : 1261 - 1273
  • [49] Gestational weight gain as an independent risk factor for adverse pregnancy outcomes in women with gestational diabetes
    Macri, F.
    Pitocco, D.
    Di Pasquo, E.
    Salvi, S.
    Rizzi, A.
    Di Leo, M.
    Tartaglione, L.
    Di Stasio, E.
    Lanzone, A.
    De Carolis, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (14) : 4403 - 4410
  • [50] Association between gestational weight gain in women with gestational diabetes mellitus and adverse pregnancy outcomes: a retrospective cohort study
    Shi, Ping
    Liu, Aimin
    Yin, Xiaoyan
    BMC PREGNANCY AND CHILDBIRTH, 2021, 21 (01)